Quick Takeaways
- Frazier Life Sciences Public Fund, L.P. filed SCHEDULE 13G/A for Maze Therapeutics, Inc. Common Stock - par value $0.001 per share (MAZE).
- Disclosed ownership: 7.7%.
- Date of event: 30 Jun 2025.
Frazier Life Sciences Public Fund, L.P. - 30 Jun 2025 SCHEDULE 13G/A Report for Maze Therapeutics, Inc. Common Stock - par value $0.001 per share (MAZE)
- Filing Manager
- Frazier Life Sciences Public Fund, L.P.
- Reporting Manager
- Frazier Life Sciences Public Fund, L.P.
- Symbol
- MAZE
- Shares outstanding
- 43,544,351 shares
- Disclosed Ownership
- 3,352,915 shares
- Ownership
- 7.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 Aug 2025, 13:43:15 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 29 Apr 2025
- Next filing
- 13 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Frazier Life Sciences Public Fund, L.P. disclosed 7.7% ownership in Maze Therapeutics, Inc. Common Stock - par value $0.001 per share (MAZE) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 29 Apr 2025.
- Current filing was accepted on 14 Aug 2025, 13:43.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (17)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 7.7% | 3,352,915 | 0 | 3,352,915 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P. | |
| FHMLSP, L.P. | 7.7% | 3,352,915 | 0 | 3,352,915 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P. | |
| FHMLSP, L.L.C. | 7.7% | 3,352,915 | 0 | 3,352,915 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP, L.L.C. | |
| Frazier Life Sciences Public Overage Fund, L.P. | 2.3% | 989,351 | 0 | 989,351 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P., GP of Frazier Life Sciences Public Overage Fund, L.P. | |
| FHMLSP Overage, L.P. | 2.3% | 989,351 | 0 | 989,351 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P. | |
| FHMLSP Overage, L.L.C. | 2.3% | 989,351 | 0 | 989,351 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C. | |
| Frazier Life Sciences X, L.P. | 0.2% | 75,982 | 0 | 75,982 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P. | |
| FHMLS X, L.P. | 0.2% | 75,982 | 0 | 75,982 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P. | |
| FHMLS X, L.L.C. | 0.2% | 75,982 | 0 | 75,982 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS X, L.L.C. | |
| Frazier Life Sciences XI, L.P. | 0.3% | 149,026 | 0 | 149,026 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P. | |
| FHMLS XI, L.P. | 0.3% | 149,026 | 0 | 149,026 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P. | |
| FHMLS XI, L.L.C. | 0.3% | 149,026 | 0 | 149,026 | /s/ Steve R. Bailey | By Steve R. Bailey, CFO of FHMLS XI, L.L.C. | |
| James N. Topper | 0.2% | 75,982 | 0 | 75,982 | /s/ Steve R. Bailey | By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 | |
| Patrick J. Heron | 0.2% | 75,982 | 0 | 75,982 | /s/ Steve R. Bailey | By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 | |
| Albert Cha | 0% | 0 | 0 | 0 | /s/ Steve R. Bailey | By Steve R. Bailey, Attorney-in-Fact for Albert Cha, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021 | |
| James Brush | 0% | 0 | 0 | 0 | /s/ Steve R. Bailey | By Steve R. Bailey, Attorney-in-Fact for James Brush, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021 | |
| Daniel Estes | 0% | 0 | 0 | 0 | /s/ Steve R. Bailey | By Steve R. Bailey, Attorney-in-Fact for Daniel Estes, pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022 |